• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨质疏松症的病理生理学:护理干预与管理

Physiopathology of Osteoporosis: Nursing Involvement and Management.

作者信息

Valenzuela-Martínez Sandra, Ramírez-Expósito María Jesús, Carrera-González María Pilar, Martínez-Martos José Manuel

机构信息

Experimental and Clinical Physiopathology Research Group CTS-1039, Department of Health Sciences, Faculty of Health Sciences, University of Jaén, Campus Universitario Las Lagunillas, 23009 Jaén, Spain.

Department of Nursing, Pharmacology and Physiotherapy, Faculty of Medicine and Nursing, Maimonides Institute of Biomedical Research of Córdoba (IMIBIC) IMIBIC Building, Reina Sofia University Hospital, Av. Menéndez Pidal, s/n, 14004 Córdoba, Spain.

出版信息

Biomedicines. 2023 Apr 19;11(4):1220. doi: 10.3390/biomedicines11041220.

DOI:10.3390/biomedicines11041220
PMID:37189837
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10136116/
Abstract

Osteoporosis is a major public health problem today. We are facing an aging society where the average life expectancy continues to increase. Osteoporosis affects more than 30% of postmenopausal women due to hormonal changes that occur during this time. Postmenopausal osteoporosis is therefore of particular concern. The aim of this review is to identify the etiology, pathophysiology, diagnosis and treatment of this disease and lay the foundation for the role nurses should play in preventing postmenopausal osteoporosis. Several risk factors are associated with osteoporosis. In addition to age and sex, genetics, ethnicity, diet, or the presence of other disorders determine the development of this disease. The key factors include exercise, a balanced diet, and high levels of vitamin D. This is primarily from a solar source, and infancy is the time when future bone formation is greatest. There are now medications that can complement these preventive measures. The work of nursing staff is not only prevention, but also early detection and early treatment. In addition, imparting information and knowledge about the disease to the population is key to preventing an osteoporosis epidemic. In this study, a detailed description is provided of the biological and physiological disease, the preventive measures currently being researched, the information currently available to the population, and how health professionals address osteoporosis from a preventive perspective.

摘要

骨质疏松症是当今一个重大的公共卫生问题。我们正面临着一个老龄化社会,平均预期寿命持续增长。由于绝经期间发生的激素变化,超过30%的绝经后女性受到骨质疏松症的影响。因此,绝经后骨质疏松症尤其令人关注。本综述的目的是确定这种疾病的病因、病理生理学、诊断和治疗方法,并为护士在预防绝经后骨质疏松症中应发挥的作用奠定基础。骨质疏松症与多种风险因素相关。除了年龄和性别外,遗传、种族、饮食或其他疾病的存在决定了这种疾病的发展。关键因素包括运动、均衡饮食和高水平的维生素D。维生素D主要来自阳光照射,婴儿期是未来骨骼形成最旺盛的时期。现在有一些药物可以补充这些预防措施。护理人员的工作不仅包括预防,还包括早期发现和早期治疗。此外,向公众传授有关该疾病的信息和知识是预防骨质疏松症流行的关键。在本研究中,详细描述了该疾病的生物学和生理学特征、目前正在研究的预防措施、公众目前可获得的信息,以及卫生专业人员如何从预防角度应对骨质疏松症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f32/10136116/36c388e8b012/biomedicines-11-01220-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f32/10136116/36c388e8b012/biomedicines-11-01220-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f32/10136116/36c388e8b012/biomedicines-11-01220-g001.jpg

相似文献

1
Physiopathology of Osteoporosis: Nursing Involvement and Management.骨质疏松症的病理生理学:护理干预与管理
Biomedicines. 2023 Apr 19;11(4):1220. doi: 10.3390/biomedicines11041220.
2
Osteoporosis: new hope for the future.骨质疏松症:未来的新希望。
Int J Fertil Womens Med. 1997 Jul-Aug;42(4):245-54.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Management of postmenopausal osteoporosis: position statement of the North American Menopause Society.绝经后骨质疏松症的管理:北美更年期协会立场声明
Menopause. 2002 Mar-Apr;9(2):84-101.
5
Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.绝经后妇女骨质疏松症的管理:北美绝经学会 2010 年立场声明。
Menopause. 2010 Jan-Feb;17(1):25-54; quiz 55-6. doi: 10.1097/gme.0b013e3181c617e6.
6
The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil.绝经后骨质疏松症的流行病学与管理:来自巴西的观点
Clin Interv Aging. 2015 Mar 20;10:583-91. doi: 10.2147/CIA.S54614. eCollection 2015.
7
Physical activity in the prevention and amelioration of osteoporosis in women : interaction of mechanical, hormonal and dietary factors.体育活动在预防和改善女性骨质疏松症中的作用:机械、激素和饮食因素的相互作用
Sports Med. 2005;35(9):779-830. doi: 10.2165/00007256-200535090-00004.
8
[The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].[激素替代疗法对绝经后女性骨密度的影响:取决于维生素D受体(VDR)和雌激素受体(ER)基因的多态性]
Ann Acad Med Stetin. 2003;49:111-30.
9
Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.迈向充满活力的超老龄社会:日本的医学与社会的未来。
Geriatr Gerontol Int. 2021 Aug;21(8):601-613. doi: 10.1111/ggi.14201. Epub 2021 Jul 1.
10
Osteoporosis: preventive strategies.骨质疏松症:预防策略
Int J Fertil Womens Med. 1998 Mar-Apr;43(2):56-64.

引用本文的文献

1
Association of dietary patterns with osteoporosis risk: a meta-analysis of observational studies.饮食模式与骨质疏松症风险的关联:观察性研究的荟萃分析
J Orthop Surg Res. 2025 May 30;20(1):551. doi: 10.1186/s13018-025-05896-9.
2
Myocyte-Specific Enhancer Factor 2A Potentiates Osteoclastic Differentiation in Osteoporosis by Inducing Endothelin Receptor Type A.心肌细胞特异性增强子因子2A通过诱导A型内皮素受体增强骨质疏松症中的破骨细胞分化。
Biochem Genet. 2025 May 14. doi: 10.1007/s10528-025-11135-x.
3
A comprehensive review and advanced biomolecule-based therapies for osteoporosis.

本文引用的文献

1
Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group.维生素 D 补充在肌肉骨骼疾病管理中的作用:来自欧洲临床和骨骼肌肉疾病经济方面学会(ESCEO)工作组的最新更新。
Aging Clin Exp Res. 2022 Nov;34(11):2603-2623. doi: 10.1007/s40520-022-02279-6. Epub 2022 Oct 26.
2
A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis.一项罗莫佐单抗治疗绝经后骨质疏松症的疗效和安全性的系统评价和荟萃分析。
Osteoporos Int. 2022 Jan;33(1):1-12. doi: 10.1007/s00198-021-06095-y. Epub 2021 Aug 25.
3
骨质疏松症的综合综述及基于生物分子的先进疗法。
J Adv Res. 2025 May;71:337-354. doi: 10.1016/j.jare.2024.05.024. Epub 2024 May 27.
4
Irisin and Its Role in Postmenopausal Osteoporosis and Sarcopenia.鸢尾素及其在绝经后骨质疏松症和肌肉减少症中的作用。
Biomedicines. 2024 Apr 22;12(4):928. doi: 10.3390/biomedicines12040928.
5
Carbamazepine regulates USP10 through miR-20a-5p to affect the deubiquitination of SKP2 and inhibit osteogenic differentiation.卡马西平通过 miR-20a-5p 调控 USP10 影响 SKP2 的去泛素化从而抑制成骨分化。
J Orthop Surg Res. 2023 Nov 1;18(1):820. doi: 10.1186/s13018-023-04169-7.
6
A diagnostic approach integrated multimodal radiomics with machine learning models based on lumbar spine CT and X-ray for osteoporosis.基于腰椎 CT 和 X 射线的多模态放射组学与机器学习模型相结合的骨质疏松症诊断方法。
J Bone Miner Metab. 2023 Nov;41(6):877-889. doi: 10.1007/s00774-023-01469-0. Epub 2023 Oct 28.
7
Review on the protective activity of osthole against the pathogenesis of osteoporosis.蛇床子素对骨质疏松症发病机制的保护作用综述
Front Pharmacol. 2023 Aug 23;14:1236893. doi: 10.3389/fphar.2023.1236893. eCollection 2023.
Interaction between bone and immune cells: Implications for postmenopausal osteoporosis.
骨骼与免疫细胞之间的相互作用:对绝经后骨质疏松症的影响。
Semin Cell Dev Biol. 2022 Mar;123:14-21. doi: 10.1016/j.semcdb.2021.05.014. Epub 2021 May 20.
4
Effects of combined calcium and vitamin D supplementation on osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.联合补充钙和维生素D对绝经后女性骨质疏松症的影响:一项随机对照试验的系统评价和荟萃分析
Food Funct. 2020 Dec 1;11(12):10817-10827. doi: 10.1039/d0fo00787k. Epub 2020 Nov 25.
5
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update.绝经后妇女骨质疏松症的药物治疗:内分泌学会指南更新。
J Clin Endocrinol Metab. 2020 Mar 1;105(3). doi: 10.1210/clinem/dgaa048.
6
Postmenopausal Osteoporosis: The Role of Lifestyle in Maintaining Bone Mass and Reducing Fracture Risk.绝经后骨质疏松症:生活方式在维持骨量和降低骨折风险中的作用
Am J Lifestyle Med. 2016 Dec 16;11(2):125-128. doi: 10.1177/1559827616682938. eCollection 2017 Mar-Apr.
7
Muscle and Bone Health in Postmenopausal Women: Role of Protein and Vitamin D Supplementation Combined with Exercise Training.绝经后妇女的肌肉和骨骼健康:蛋白质和维生素 D 补充与运动训练的作用。
Nutrients. 2018 Aug 16;10(8):1103. doi: 10.3390/nu10081103.
8
Evaluating The Risk Of Osteoporosis Through Bone Mass Density.通过骨密度评估骨质疏松症风险。
J Ayub Med Coll Abbottabad. 2016 Oct-Dec;28(4):730-733.
9
Profile of romosozumab and its potential in the management of osteoporosis.罗莫单抗简介及其在骨质疏松症管理中的潜力。
Drug Des Devel Ther. 2017 Apr 13;11:1221-1231. doi: 10.2147/DDDT.S127568. eCollection 2017.
10
Risk Factors for Osteoporosis in Postmenopausal Women.绝经后女性骨质疏松症的危险因素
Med Arch. 2017 Feb;71(1):25-28. doi: 10.5455/medarh.2017.71.25-28. Epub 2017 Feb 5.